key: cord-0821796-4yqz5w26
authors: Rozental, Olga; Thalappillil, Richard; White, Robert S.; Kumar, Shreyajit R.; Tam, Christopher W.
title: Hemodynamic Monitoring Options in COVID-19
date: 2020-05-06
journal: J Cardiothorac Vasc Anesth
DOI: 10.1053/j.jvca.2020.04.050
sha: b896f9bd9efbf48c4ab4389f0bd10d776acf29a6
doc_id: 821796
cord_uid: 4yqz5w26

nan

dysfunction. 1,2 Among the most susceptible populations at risk for severe infection are patients with cardiovascular comorbidities, such as hypertension, diabetes mellitus, coronary artery disease, and cardiomyopathy, who have a higher representation among non-survivors. 2, 3 Although pulmonary pathophysiologic processes undoubtedly underlie the perilous COVID-19 course, the emergence of cardiac injury later in the disease could have major implications for outcomes. Markers of myocardial injury, such as troponin and N-terminal pro-brain natriuretic peptide (NT-proBNP), have been shown to increase rapidly in non-survivors. 2, 3 Although cardiovascular disease appears to predispose some patients to COVID-19-related myocardial injury, acute myopericarditis in the absence of prior disease has also been described, even without signs of interstitial pneumonia. 4 ARDS mechanical ventilation with high positive endexpiratory pressure (PEEP) along with the presence of intravascular thrombosis in the setting of sepsis-induced coagulopathy could increase susceptibility to pulmonary hypertension, right heart dysfunction, and end-organ (e.g. kidney) hypoperfusion. 5 The risk of cardiovascular and renal injury in conjunction with the importance of conservative fluid management as a key tenet of ARDS treatment justifies the need for judicious monitoring of intravascular volume status in the COVID-19 cohort. 6 We reflect on the clinical utility of select popular hemodynamic monitoring devices and suggest that the pulmonary artery catheter (PAC) shows empirical promise as a validated tool that maximizes monitoring capabilities and minimizes expenditure of hospital resources.

It is difficult to estimate intravascular volume with current standard of care monitors, which could delay the timely identification of end-organ hypoperfusion and increase the risk of morbidity and mortality. Pulmonary artery catheters (PACs) can measure right atrial or ventricular pressures, pulmonary arterial pressures, and continuous mixed venous oxygen saturation (SvO 2 ), in addition to having the capabilities to estimate systemic (SVR) and pulmonary vascular resistance (PVR), as well as cardiac output (CO) ( Table 1) . 7 Together, these parameters could provide valuable information about volume status and cardiac function.

Patients afflicted with pulmonary hypertension and/or right heart dysfunction secondary to coagulopathy could benefit from PAC-based management of discordant right and left ventricular failure under the guidance of PVR, right ventricular ejection fraction (RVEF), and SvO 2 . 5,8 High PVR, low RVEF, and low SvO 2 , for instance, might suggest a need for inotropes. Furthermore, accurate estimations of stroke volume could also help avert pre-renal kidney injury. However, we recognize that PA catheterization is not without its limitations and risks. High intrathoracic pressures in the setting of a high PEEP strategy to improve oxygenation in ARDS could lead to overestimation of left ventricular volumes based on PA diastolic pressures. High PEEP could also theoretically increase the risk of PA perforation, one of the most feared complications of PAC use. In addition, the effectiveness of PAC-derived data in significantly altering clinical outcomes still remains equivocal. 9 Nevertheless, we propose that the PAC maximizes resource utilization in the COVID-19 ICU arena by providing continuous assessments of intravascular volume and cardiac function while limiting staff exposure and personal protective equipment

The past three decades have seen the emergence of alternative devices to PACs, which are thought to provide similar hemodynamic information in a minimally invasive manner.

Minimally invasive technologies can utilize principles of transpulmonary thermodilution or indicator dye dilution, as well as arterial waveform variation analysis from arterial catheters.

These monitors gauge cardiac function through estimations of cardiac output; they can also evaluate intravascular volume status and likelihood of response to a fluid challenge through stroke volume variation (SVV) and pulse pressure variation (PPV). 10 Examples include the Pulse index Contour Cardiac Output (PiCCO), Lithium Dilution Cardiac Output (LiDCO), and FloTrac devices (Table 1 ). The PiCCO system is unique in its ability to provide volumetric assessments of preload (global end-diastolic volume) and pulmonary edema (extravascular lung water, pulmonary vascular permeability index). 11 PiCCO guidance may be associated with a shorter duration of respiratory support and faster recovery of PaO 2 /FiO 2 ratios in ARDS patients, perhaps because optimization of extravascular lung water serves as a positive prognostic factor. 12, 13 The LiDCO system provides comparable CO measurements to PACs, but unlike the PiCCO, it has not been examined in ARDS patients managed with a high PEEP strategy; furthermore, the LiDCO is not reliable in the setting of muscle relaxation, given that quaternary ammonium ion-based agents may interfere with the lithium sensor. 10, 14 The FloTrac monitor has also gained popularity as an easy-to-use, operator independent system, but the accuracy of FloTrac-derived CO measurements remains equivocal. 15 Furthermore, unlike the PiCCO and LiDCO monitors, the FloTrac system may not be reliable in septic patients with low SVR, nor could FloTrac-derived SVV be utilized for fluid optimization as it is poorly predictive of volume responsiveness. 10 Non-invasive monitors rely on quantification of thoracic impedance variability, ultrasound imaging, and measurement of velocity-time integrals from Doppler signals to provide information about CO (Table 1 ). The Non-invasive Cardiac Output Monitoring (NICOM) device analyzes phase shifts in the voltage of electrical impulses passed between electrodes on either side of the body; it provides accurate CO values in mechanically ventilated patients that correlate with fluid responsiveness, irrespective of hemodynamic instability or arrhythmias, though it has yet to be studied in the context of ARDS management. 10 Ultrasound-based technologies, such as esophageal Doppler and echocardiography, have mass appeal as they are also reliable in their real-time assessment of CO and fluid responsiveness. 10 The armamentarium of hemodynamic monitoring devices should be exploited to augment therapeutic tactics for conservative fluid management in a population that is vulnerable to sustaining multi-organ injury. The PAC is a promising option that maximizes monitoring capabilities while limiting exposure of healthcare workers and depletion of highly coveted PPE.

The PiCCO may be a viable less-invasive alternative as it has been trialed in ARDS patients previously, while other monitors still have questionable accuracy and/or applicability in ARDS management with a high PEEP strategy. The COVID-19 landscape should serve as a launching pad for randomized controlled trials to evaluate whether device-driven management promotes beneficial patient outcomes. 

Clinical Characteristics of Coronavirus Disease 2019 in China

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)

Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19)

Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy

Treatment for severe acute respiratory distress syndrome from COVID-19

Right Heart Catheterization for the Diagnosis of Pulmonary Hypertension: Controversies and Practical Issues

Which cardiac surgical patients can benefit from placement of a pulmonary artery catheter?

Its Evolution Over the Past Half Century

Noninvasive cardiac output monitors: a state-of the-art review

Alternatives to the Swan-Ganz catheter

ICU management based on PiCCO parameters reduces duration of mechanical ventilation and ICU length of stay in patients with severe thoracic trauma and acute respiratory distress syndrome

Extravascular lung water in sepsis-associated acute respiratory distress syndrome: indexing with predicted body weight improves correlation with severity of illness and survival

Arterial waveform analysis in anesthesia and critical care

Evaluation of the Fourth-Generation FloTrac/Vigileo System in Comparison With the Intermittent Bolus Thermodilution Method in Patients Undergoing Cardiac Surgery

Guidelines for the use of echocardiography as a monitor for therapeutic intervention in adults: a report from the American Society of Echocardiography